[Form 4] ARGAN INC Insider Trading Activity

Rhea-AI Filing Summary

Argan Inc. (AGX) director Peter W. Getsinger reported open‑market sales of the company’s common stock. He sold 2,000 shares at $292 on October 17, 2025 and 6,493 shares at $294.39 on October 20, 2025.

Following these transactions, he directly holds 9,897 shares of Argan common stock. The filing identifies him as a Director and lists the transactions as open‑market sales reported on a Form 4.

Insights

Insider transactions specialist

Routine director share sales disclosed; neutral impact.

Peter W. Getsinger, a director of Argan Inc., reported two open‑market sales: 2,000 shares at $292 on October 17, 2025 and 6,493 shares at $294.39 on October 20, 2025. These are standard Form 4 disclosures of insider activity.

After the sales, he directly holds 9,897 shares. The filing does not state any corporate action tied to these trades, and it lists direct ownership form for the remaining shares.

Insider sale impact depends on context such as trading plans and personal portfolio decisions. The disclosure here provides prices, dates, and post‑transaction holdings; actual market effect, if any, would hinge on broader trading activity and liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Getsinger Peter W

(Last) (First) (Middle)

4075 WILSON BOULEVARD

SUITE 440

(Street)

ARLINGTON VA 22203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/17/2025		S		2,000(1)	D	$292	16,390	D
Common Stock	10/20/2025		S		6,493(2)	D	$294.39	9,897	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 17, 2025, the Reporting Person sold 2,000 shares of the Issuer's common stock on the open market at an average price of $292 per share.

2. On October 20, 2025, the Reporting Person sold 6,493 shares of the Issuer's common stock on the open market at an average price of $294.39 per share.

	/s/ Peter W. Getsinger	10/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AGX report in this Form 4?

A director sold 2,000 shares at $292 on Oct 17, 2025 and 6,493 shares at $294.39 on Oct 20, 2025.

How many AGX shares does the director hold after these sales?

Following the transactions, the director directly holds 9,897 shares.

What was the method of sale for the AGX shares?

Both transactions were open‑market sales of Argan common stock.

Who is the reporting person in the AGX Form 4?

The reporting person is Peter W. Getsinger, identified as a Director of Argan Inc.

On which dates did the AGX insider trades occur?

The trades occurred on October 17, 2025 and October 20, 2025.

What were the average sale prices reported for the AGX trades?

The reported average prices were $292.00 and $294.39 per share.